Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 5 Insider Annual Insider Trading Report
  2. 4 Insider Changes in Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 32,050 shares at $3.12 ($99,996)
  7. 4 Open-market buy Director bought 32,050 shares at $3.12 ($99,996)
  8. 4 Other acquisition Director acquired 4,040,523 shares (other)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Director bought 370,000 shares at $2.65 ($980,500)
  11. 4 Open-market sale Sr. VP, COO, and CFO sold 100,000 shares at $2.65 ($265,000)
  12. 4 Open-market sale Chief Executive Officer sold 270,000 shares at $2.65 ($715,500)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 50,000 shares (option exercise)

Page 15 of 37 · 722 filings